QNT Stock Analysis: Quantinuum Common Stock | NASDAQ
Software - Application | NASDAQ, USA | Market Cap: 14.536m USD | 12M Return: 18.8% | US74768A1043 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 71.1M
Warnings
Tailwinds
Seasonality 0.1 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Quantinuum Inc. (NASDAQ: QNT) is a U.S.-based quantum computing company that designs and develops both the hardware and software components of its integrated quantum computing platform. Founded in 2021 and headquartered in Broomfield, Colorado, the company operates domestically and internationally, offering a full-stack solution that combines quantum hardware systems, middleware, developer tools, application libraries, and targeted intellectual property aimed at making quantum computing usable in real-world applications.
Quantinuum pursues a full-stack business model, providing the underlying physical quantum systems alongside the software layers needed to program and deploy them, which is a common approach among integrated quantum computing vendors. The company is classified within the Technology sector, specifically the application software industry, reflecting its emphasis on deployable quantum-enabled software as well as hardware.
- Trapped-ion quantum hardware leadership faces IBM and Google competition
- Government contracts anchor revenue as commercial monetization remains nascent
- Elevated R&D spending continues amid post-IPO capital deployment phase
| Net Income: -71.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.07 > 0.02 and ΔFCF/TA 5.61 > 1.0 |
| NWC/Revenue: 7.23k% < 20% (prev 731.5%; Δ 6.50k% < -1%) |
| CFO/TA -0.05 > 3% & CFO -160.3m > Net Income -71.5m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 36.61 > 1.5 & < 3 |
| Outstanding Shares: last fiscal year (33.2m) vs prev -4.20% < -2% |
| Gross Margin: 62.16% > 18% (prev 52.97%; Δ 9.19% > 0.5%) |
| Asset Turnover: 1.39% > 50% (prev 2.15%; Δ -0.75% > 0%) |
| Interest Coverage Ratio: error (cannot be calculated; needs correct EBIT TTM and Interest Expense TTM) |
| A: 0.66 (Total Current Assets 2.30b - Total Current Liabilities 62.8m) / Total Assets 3.36b |
| B: -0.00 (Retained Earnings -11.3m / Total Assets 3.36b) |
| C: -0.26 (EBIT TTM -568.0m / Avg Total Assets 2.22b) |
| D: 2.88 (Book Value of Equity 406.0m / Total Liabilities 140.9m) |
| Altman-Z'' = 5.65 = AAA |
| DSRI: 0.23 (Receivables 4.04m/13.0m, Revenue 30.9m/23.0m) |
| GMI: 0.85 (GM 52.97% / 62.16%) |
| AQI: 0.36 (AQ_t 0.27 / AQ_t-1 0.74) |
| SGI: 1.35 (Revenue 30.9m / 23.0m) |
| TATA: 0.03 (NI -71.5m - CFO -160.3m) / TA 3.36b) |
| Beneish M = -3.92 (Cap -4..+1) = AAA |
As of August 13, 2026, the stock is trading at USD 71.74 with a total of 4,554,271 shares traded. Over the past week, the price has changed by +26.06%, over one month by +11.94%, over three months by +18.81% and over the past year by +18.81%.
Current recommended Stop Loss: 65.30 (which is 9% or 1.2 ATR below the current price).
Quantinuum Common Stock has no consensus analysts rating.
P/S = 850.878
P/B = 4.3731
Revenue TTM = 30.9m USD
EBIT TTM = -568.0m USD
EBITDA TTM = -538.2m USD
Long Term Debt = 22.0m USD (estimated: total debt 24.8m - short term 2.78m)
Short Term Debt = 2.78m USD (from shortTermDebt, last quarter)
Debt = 46.8m USD (from shortLongTermDebtTotal, last quarter) + Leases 22.0m
Net Debt = -2.22b USD (calculated: Debt 46.8m - CCE 2.27b)
Enterprise Value = 12.3b USD (14.5b + Debt 46.8m - CCE 2.27b)
Interest Coverage Ratio = unknown (Ebit TTM -568.0m / Interest Expense TTM 0.0)
EV/FCF = -52.32x (Enterprise Value 12.3b / FCF TTM -235.3m)
FCF Yield = -1.91% (FCF TTM -235.3m / Enterprise Value 12.3b)
FCF Margin = -760.9% (FCF TTM -235.3m / Revenue TTM 30.9m)
Net Margin = -231.3% (Net Income TTM -71.5m / Revenue TTM 30.9m)
Gross Margin = 62.16% ((Revenue TTM 30.9m - Cost of Revenue TTM 11.7m) / Revenue TTM)
Gross Margin QoQ = none% (prev none%)
Tobins Q-Ratio = 3.66 (Enterprise Value 12.3b / Total Assets 3.36b)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt 46.8m)
Taxrate = 21.0% (US federal default 21%)
NOPAT = -448.7m (EBIT -568.0m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 36.61 (Total Current Assets 2.30b / Total Current Liabilities 62.8m)
Debt / Equity = 0.12 (Debt 46.8m / totalStockholderEquity, last quarter 406.0m)
Debt / EBITDA = 4.13 (negative EBITDA) (Net Debt -2.22b / EBITDA -538.2m)
Debt / FCF = 9.44 (negative FCF - burning cash) (Net Debt -2.22b / FCF TTM -235.3m)
Total Stockholder Equity = 1.69b (last fiscal year from totalStockholderEquity)
RoA = -3.23% (Net Income -71.5m / Total Assets 3.36b)
RoE = -4.24% (Net Income TTM -71.5m / Total Stockholder Equity 1.69b)
RoCE = -33.22% (EBIT -568.0m / Capital Employed (Equity 1.69b + L.T.Debt 22.0m))
RoIC = -13.58% (negative operating profit) (NOPAT -448.7m / Invested Capital 3.30b)
WACC = 19.68% (E(14.5b)/V(14.6b) * Re(19.74%) + D(46.8m)/V(14.6b) * Rd(0.0%) * (1-Tc(0.21)))
Discount Rate = 19.74% (= CAPM, Blume Beta Adj.) -> capped to 13.17%
Shares (yearly) Correlation: 0.0 | Cagr: 0.0%
[DCF] Fair Price = unknown (Cash Flow -235.3m)
Revenue Correlation: N/A | Revenue CAGR: N/A | SUE: N/A | # QB: 0
EPS current Quarter (2026-09-30): EPS=-0.35 | Chg30d=N/A | Revisions=+0% | Analysts=11
EPS current Year (2026-12-31): EPS=-1.40 | Chg30d=N/A | Revisions=+0% | GrowthEPS=+0.0% | GrowthRev=+0.0%
EPS next Year (2027-12-31): EPS=-1.57 | Chg30d=N/A | Revisions=+0% | GrowthEPS=-11.8% | GrowthRev=+67.5%
[Analyst] Revisions Ratio: +0% (up=0, down=0)